-
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.
-
Perkins in Winter Springs confirmed that it's the newest participant. Its back room will become a refuge for those diners every Tuesday afternoon.
-
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
-
Caregivers can use puzzles, blankets, comfort food and other tools to help distract their loved one with dementia from the often chaotic environment that comes with sheltering from a hurricane.
-
An atlas showing how Alzheimer's changes individual brain cells could help researchers find new treatments for the disease.
-
Because people with Down syndrome are very likely to develop Alzheimer's, they are ideal candidates for experimental drugs meant to halt the disease.
-
The law directs the Florida Department of Health, through existing programs, to educate health care providers about issues such as the importance of early detection of dementia.
-
Jerri Edwards, a professor of psychiatry and behavioral neurosciences at the USF Health Morsani College of Medicine, talks about the study.
-
HHS Xavier Becerra said the 2022 premium should be adjusted downward, but legal and operational hurdles prevented officials from doing that in the middle of the year.
-
On the Florida Roundup: New research predicts Florida will have one of the fastest growing rates of Alzheimer’s dementia by the middle of this decade.